Go Back
Phosphorylations for 'EPB49'
| Source | Sequence | Kinase Gene | Detection Level | Kinase Description | Reference | Experiment type |
|---|---|---|---|---|---|---|
| T 10 (1) | ||||||
| RLQKQPLTSPGSVSP | GSK3A | glycogen synthase kinase 3 alpha | ||||
| RLQKQPLTSPGSVSP | GSK3B | glycogen synthase kinase 3 beta | ||||
| S 14 (1) | ||||||
| QPLTSPGSVSPSRDS | GSK3A | glycogen synthase kinase 3 alpha | ||||
| QPLTSPGSVSPSRDS | GSK3B | glycogen synthase kinase 3 beta | ||||
| S 16 (1) | ||||||
| LTSPGSVSPSRDSSV | CDK2 | cyclin-dependent kinase 2 | ||||
| LTSPGSVSPSRDSSV | CDK2 | cyclin-dependent kinase 2 | ||||
| LTSPGSVSPSRDSSV | MAPK14 | mitogen-activated protein kinase 14 | ||||
| LTSPGSVSPSRDSSV | MAPK11 | mitogen-activated protein kinase 11 | ||||
| LTSPGSVSPSRDSSV | MAPK13 | mitogen-activated protein kinase 13 | ||||
| S 22 (1) | ||||||
| VSPSRDSSVPGSPSS | ACVR2A | activin A receptor, type IIA | ||||
| VSPSRDSSVPGSPSS | ACVR2B | activin A receptor, type IIB | ||||
| VSPSRDSSVPGSPSS | DMPK | dystrophia myotonica-protein kinase | ||||
| VSPSRDSSVPGSPSS | GSK3A | glycogen synthase kinase 3 alpha | ||||
| VSPSRDSSVPGSPSS | GSK3B | glycogen synthase kinase 3 beta | ||||
| VSPSRDSSVPGSPSS | GSK3B | glycogen synthase kinase 3 beta | ||||
| VSPSRDSSVPGSPSS | TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | ||||
| VSPSRDSSVPGSPSS | PIM2 | pim-2 oncogene | ||||
| S 26 (1) | ||||||
| RDSSVPGSPSSIVAK | CDK1 | cyclin-dependent kinase 1 | ||||
| RDSSVPGSPSSIVAK | CDK2 | cyclin-dependent kinase 2 | ||||
| RDSSVPGSPSSIVAK | GSK3B | glycogen synthase kinase 3 beta | ||||
| RDSSVPGSPSSIVAK | MAPK8 | mitogen-activated protein kinase 8 | ||||
| S 28 (1) | ||||||
| SSVPGSPSSIVAKMD | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | ||||
| SSVPGSPSSIVAKMD | PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | ||||
| SSVPGSPSSIVAKMD | PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | ||||
| SSVPGSPSSIVAKMD | PKN1 | protein kinase N1 | ||||
| S 92 (1) | ||||||
| SLSPKSTSPPPSPEV | CDK2 | cyclin-dependent kinase 2 | ||||
| SLSPKSTSPPPSPEV | CDK5 | cyclin-dependent kinase 5 | ||||
| SLSPKSTSPPPSPEV | GSK3B | glycogen synthase kinase 3 beta | ||||
| SLSPKSTSPPPSPEV | MAPK8 | mitogen-activated protein kinase 8 | ||||
| S 96 (1) | ||||||
| KSTSPPPSPEVWADS | CDK2 | cyclin-dependent kinase 2 | ||||
| KSTSPPPSPEVWADS | CDK5 | cyclin-dependent kinase 5 | ||||
| KSTSPPPSPEVWADS | GSK3B | glycogen synthase kinase 3 beta | ||||
| KSTSPPPSPEVWADS | MAPK8 | mitogen-activated protein kinase 8 | ||||
| S 105 (1) | ||||||
| EVWADSRSPGIISQA | CDK2 | cyclin-dependent kinase 2 | ||||
| EVWADSRSPGIISQA | CDK5 | cyclin-dependent kinase 5 | ||||
| EVWADSRSPGIISQA | MAPK14 | mitogen-activated protein kinase 14 | ||||
| EVWADSRSPGIISQA | GSK3B | glycogen synthase kinase 3 beta | ||||
| EVWADSRSPGIISQA | MAPK11 | mitogen-activated protein kinase 11 | ||||
| EVWADSRSPGIISQA | MAPK13 | mitogen-activated protein kinase 13 | ||||
| S 156 (1) | ||||||
| QRESVGGSPQTKHLI | CDK1 | cyclin-dependent kinase 1 | ||||
| QRESVGGSPQTKHLI | CDK2 | cyclin-dependent kinase 2 | ||||
| QRESVGGSPQTKHLI | MAPK14 | mitogen-activated protein kinase 14 | ||||
| QRESVGGSPQTKHLI | GSK3B | glycogen synthase kinase 3 beta | ||||
| QRESVGGSPQTKHLI | MAPK11 | mitogen-activated protein kinase 11 | ||||
| QRESVGGSPQTKHLI | MAPK13 | mitogen-activated protein kinase 13 | ||||
| S 226 (1) | ||||||
| EEEEDDDSGEEMKAL | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| EEEEDDDSGEEMKAL | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ||||
| EEEEDDDSGEEMKAL | CSNK2A2 | casein kinase 2, alpha prime polypeptide | ||||
| S 289 (1) | ||||||
| QGTSKSSSLPAYGRT | ACVR2A | activin A receptor, type IIA | ||||
| QGTSKSSSLPAYGRT | ACVR2B | activin A receptor, type IIB | ||||
| QGTSKSSSLPAYGRT | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| QGTSKSSSLPAYGRT | AKT2 | v-akt murine thymoma viral oncogene homolog 2 | ||||
| QGTSKSSSLPAYGRT | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | ||||
| QGTSKSSSLPAYGRT | PRKCA | protein kinase C, alpha | ||||
| QGTSKSSSLPAYGRT | PRKCD | protein kinase C, delta | ||||
| QGTSKSSSLPAYGRT | PRKCG | protein kinase C, gamma | ||||
| QGTSKSSSLPAYGRT | PRKCI | protein kinase C, iota | ||||
| QGTSKSSSLPAYGRT | PKN1 | protein kinase N1 | ||||
| QGTSKSSSLPAYGRT | PRKCQ | protein kinase C, theta | ||||
| QGTSKSSSLPAYGRT | PRKCZ | protein kinase C, zeta | ||||
| QGTSKSSSLPAYGRT | PRKDC | protein kinase, DNA-activated, catalytic polypeptide | ||||
| QGTSKSSSLPAYGRT | ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | ||||
| QGTSKSSSLPAYGRT | TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | ||||
| QGTSKSSSLPAYGRT | ROCK2 | Rho-associated, coiled-coil containing protein kinase 2 | ||||
| QGTSKSSSLPAYGRT | PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | ||||
| QGTSKSSSLPAYGRT | PAK7 | p21 protein (Cdc42/Rac)-activated kinase 7 | ||||
| S 333 (1) | ||||||
| GRMDRGNSLPCVLEQ | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
| GRMDRGNSLPCVLEQ | AKT2 | v-akt murine thymoma viral oncogene homolog 2 | ||||
| GRMDRGNSLPCVLEQ | DMPK | dystrophia myotonica-protein kinase | ||||
| GRMDRGNSLPCVLEQ | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | ||||
| S 372 (1) | ||||||
| MRLERHLSAEDFSRV | CLK1 | CDC-like kinase 1 | ||||
| MRLERHLSAEDFSRV | CLK2 | CDC-like kinase 2 | ||||
| MRLERHLSAEDFSRV | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 |